《TAIPEI TIMES》 GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns

By Jonathan Chin / Staff writer, with CNATaiwan is weighing its first-ever compensation claim over vision loss allegedly tied to prescription semaglutide, health officials said yesterday, two days after the US issued a warning about the increased “eye stroke” risks from the drug.